Login / Signup

Impaired mitophagy links mitochondrial disease to epithelial stress in methylmalonyl-CoA mutase deficiency.

Alessandro LucianiAnke SchumannMarine BerquezZhiyong ChenDaniela NieriMario FailliHuguette DebaixBeatrice Paola FestaNatsuko TokonamiAndrea RaimondiAlessio CremonesiDiego CarrellaPatrick FornyStefan KölkerFrancesca Diomedi CamasseiFrancisca DiazCarlos T MoraesDiego Di BernardoMatthias R BaumgartnerOlivier Devuyst
Published in: Nature communications (2020)
Deregulation of mitochondrial network in terminally differentiated cells contributes to a broad spectrum of disorders. Methylmalonic acidemia (MMA) is one of the most common inherited metabolic disorders, due to deficiency of the mitochondrial methylmalonyl-coenzyme A mutase (MMUT). How MMUT deficiency triggers cell damage remains unknown, preventing the development of disease-modifying therapies. Here we combine genetic and pharmacological approaches to demonstrate that MMUT deficiency induces metabolic and mitochondrial alterations that are exacerbated by anomalies in PINK1/Parkin-mediated mitophagy, causing the accumulation of dysfunctional mitochondria that trigger epithelial stress and ultimately cell damage. Using drug-disease network perturbation modelling, we predict targetable pathways, whose modulation repairs mitochondrial dysfunctions in patient-derived cells and alleviate phenotype changes in mmut-deficient zebrafish. These results suggest a link between primary MMUT deficiency, diseased mitochondria, mitophagy dysfunction and epithelial stress, and provide potential therapeutic perspectives for MMA.
Keyphrases